Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.
|Articles|May 13, 2011
Elizabeth Blasiak on the Hourly Rounding Program Results
Author(s)Elizabeth Blasiak, RN, MSN
Oncology Nurse Elizabeth Blasiak on the Results of the Hourly Rounding Program
Advertisement
Elizabeth Blasiak, RN, MSN, OCN®, Medical Oncology, Smilow Cancer Hospital at Yale New Haven Hospital, New Haven, CT, on the hourly rounding program results.
Advertisement
Related to this article
As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer treatment evolves.
At EONS 2026, a City of Hope nurse practitioner explains how shifting immunotherapy from infusion to injection can free nurse and chair time.
Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Teaching Communication as a Clinical Skill for Breast Cancer Care
2
Outpatient Tarlatamab Feasible in Community Oncology, Real-World Data Show
3
Daraxonrasib and RAS Inhibition: What Oncology Nurses Need to Know
4
Survey: 40% of Community Practices Offer or Plan Cellular Therapy
5